Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Recchiuti

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Journal of Leukocyte Biology|April 13, 2021
As a matter of fat: Leptin, monocyte hyperactivation, and COVID-19: A commentary to "Leptin correlates with monocytes activation and severe condition in COVID-19 patients"Antonio Recchiuti
Prostaglandins & Other Lipid Mediators|March 19, 2013
Resolvin D1 and its GPCRs in resolution circuits of inflammationAntonio Recchiuti
Frontiers in Pharmacology|September 10, 2014
Targeting caveolin-1 deficiency in bone marrow derived cells: a new therapeutic window for fibrotic diseases?Eleonora Cianci, Antonio Recchiuti
Frontiers in Immunology|October 25, 2012
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationAntonio Recchiuti, Charles N Serhan
Frontiers in Pharmacology|April 20, 2019
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic FibrosisAntonio Recchiuti, Domenico Mattoscio, Elisa Isopi
Thescientificworldjournal|September 4, 2007
Lipoxin receptorsMario Romano, Irene Recchia, Antonio Recchiuti
International Journal of Molecular Sciences|September 15, 2020
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and InflammationAntonio Recchiuti, Elisa Isopi, Mario Romano, et al.
Frontiers in Pharmacology|August 28, 2020
The Resolution Approach to Cystic Fibrosis InflammationAntonio Recchiuti, Sara Patruno, Roberto Plebani, et al.
FEBS Letters|February 20, 2025
Immunoregulatory mechanisms of the arachidonic acid pathway in cancerMaria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
Prostaglandins & Other Lipid Mediators|June 24, 2023
Specialized pro-resolving lipid mediators and resolution of viral diseasesGiulia Ferri, Matteo Mucci, Domenico Mattoscio, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Journal of Leukocyte Biology|April 13, 2021
As a matter of fat: Leptin, monocyte hyperactivation, and COVID-19: A commentary to "Leptin correlates with monocytes activation and severe condition in COVID-19 patients"Antonio Recchiuti
Prostaglandins & Other Lipid Mediators|March 19, 2013
Resolvin D1 and its GPCRs in resolution circuits of inflammationAntonio Recchiuti
Frontiers in Pharmacology|September 10, 2014
Targeting caveolin-1 deficiency in bone marrow derived cells: a new therapeutic window for fibrotic diseases?Eleonora Cianci, Antonio Recchiuti
Frontiers in Immunology|October 25, 2012
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationAntonio Recchiuti, Charles N Serhan
Frontiers in Pharmacology|April 20, 2019
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic FibrosisAntonio Recchiuti, Domenico Mattoscio, Elisa Isopi
Thescientificworldjournal|September 4, 2007
Lipoxin receptorsMario Romano, Irene Recchia, Antonio Recchiuti
International Journal of Molecular Sciences|September 15, 2020
Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and InflammationAntonio Recchiuti, Elisa Isopi, Mario Romano, et al.
Frontiers in Pharmacology|August 28, 2020
The Resolution Approach to Cystic Fibrosis InflammationAntonio Recchiuti, Sara Patruno, Roberto Plebani, et al.
FEBS Letters|February 20, 2025
Immunoregulatory mechanisms of the arachidonic acid pathway in cancerMaria Tredicine, Matteo Mucci, Antonio Recchiuti, et al.
Prostaglandins & Other Lipid Mediators|June 24, 2023
Specialized pro-resolving lipid mediators and resolution of viral diseasesGiulia Ferri, Matteo Mucci, Domenico Mattoscio, et al.
Pageof 6